Tandem Diabetes Care Reports First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Tandem Diabetes (TNDM) Misses Q1 EPS by 11c
April 27, 2017 4:26 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.75), $0.11 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $15.72 million.
Our first quarter results were highlighted by our sales performance, recognition of our #1 customer... More
